The Biotech Growth Trust (BIOG) Earnings Date, Estimates & Call Transcripts

The Biotech Growth Trust logo
GBX 1,354 +16.00 (+1.20%)
As of 12:28 PM Eastern

The Biotech Growth Trust Earnings Summary

The Biotech Growth Trust issued Interim earnings on November 17, 2026, reporting an EPS of -GBX 2.10. Quarterly revenue was reported to be £100 thousand. The Biotech Growth Trust currently has a trailing EPS of GBX 558 and a P/E Ratio of 2.43

Interim Earnings Resources

Actual Revenue
(Nov. 17)
GBX 10M
Get The Biotech Growth Trust Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on The Biotech Growth Trust and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

BIOG Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BIOG Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

The Biotech Growth Trust Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/17/2026Interim-GBX -2.10---GBX 10M
6/3/2026Final-GBX -1.90---GBX 43M
11/20/2025Interim-GBX -1----
11/27/2024Interim-GBX 0.20----

Earnings data for LON:BIOG shows the most recent quarter reported on 11/17/2026. New results are added as companies report their earnings.
From Our Partners